Actively Recruiting

Age: 18Years - 65Years
All Genders
Healthy Volunteers
NCT06618183

Drug Screening System Method Comparison

Led by Intelligent Bio Solutions Inc. · Updated on 2024-10-01

135

Participants Needed

3

Research Sites

18 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Prospective, open-label, single-dose, randomized, multi-site performance evaluation of the accuracy and usability Intelligent Fingerprinting Drug Screening System in the hands of intended users: "operators" and "donors."

CONDITIONS

Official Title

Drug Screening System Method Comparison

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Able to read, understand, and sign informed consent written in English before dosing
  • Completed screening within 30 days prior to dosing
  • Healthy males and non-pregnant females aged 18 to 65 years
  • Body mass index (BMI) between 18 and 30 kg/m2 and weight at least 60 kg
  • Females of childbearing potential willing to use acceptable contraception and have a negative pregnancy test at study start
  • Males willing to use acceptable contraception
  • Judged to be in good health by medical history and vital signs, with any abnormalities deemed not clinically significant
Not Eligible

You will not qualify if you...

  • Unable or unwilling to provide informed consent
  • Missing more than three digits on hands due to birth defect or injury
  • Received investigational drug within 30 days prior to dosing
  • Clinically significant illness within 30 days before the in-clinic study phase
  • History of substance abuse or mental illness within one year prior to screening
  • Pregnant females
  • Clinically significant abnormal laboratory or vital signs results
  • History of respiratory depression such as sleep apnea
  • Current severe low blood pressure (systolic less than 90 mmHg)
  • Known or suspected gastrointestinal obstruction including paralytic ileus
  • Current acute bronchial asthma or upper airway obstruction
  • History of significant allergies including food or drug allergies
  • History or current adrenal insufficiency
  • History or current kidney disease
  • Determined unsuitable for the study by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

CenExel iResearch

Decatur, Georgia, United States, 30030

Actively Recruiting

2

CenExel HRI

Berlin, New Jersey, United States, 08009

Actively Recruiting

3

CenExel HRI

Marlton, New Jersey, United States, 08053

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Drug Screening System Method Comparison | DecenTrialz